Vibrational Circular Dichroism (VCD) Chiral Assignment of Atropisomers: Application to γ-Aminobutyric Acid (GABA) Modulators Designed as Potential Anxiolytic Drugs

Abstract

Atropisomers exist when axial chirality is present as a result of conformationally restricted rotation around a single bond. The interconversion rate of the individual atropisomers is critical to the assessment of chiral stability of a drug throughout scale-up, development, production, and storage as well as in vivo pharmacokinetics. We describe the application of vibrational circular dichroism spectroscopy coupled with quantum mechanics simulations to assign the absolute axial chirality and measure the racemization half-life of a series of potential anxiolytic drugs that act as γ-aminobutyric acid modulators.

Keywords

Infrared spectroscopy Atropisomer Vibrational circular dichroism Computational chemistry.

Get full access to this article

View all access options for this article.

References

Lin

Zhang

Cheng

. “Overview of Chirality and Chiral Drugs”. In: Lin

Zhang

Cheng

, editors. Chiral Drugs: Chemistry and Biological Action. Hoboken, NJ: John Wiley and Sons, 2011. Pp. 3–28.

Williamson

M.P.

Williams

D.H.

. “Structure Revision of Antibiotic Vancomycin. Use of Nuclear Overhauser Effect Difference Spectroscopy”. J. Am. Chem. Soc. 1981. 103(22): 6580–6585.

Eveleigh

Hulme

E.C.

Schudt

Birdsall

N.J.M.

. “The Existence of Stable Enantiomers of Telenzepine and Their Stereoselective Interaction with Muscarinic Receptor Subtypes”. Mol. Pharmacol. 1989. 35(4): 477–483.

Clayden

Moran

W.J.

Edwards

P.J.

Laplante

S.R.

. “The Challenge of Atropisomerism in Drug Discovery”. Angew. Chem. Int. Ed. 2009. 48(35): 6398–6402.

Laplante

S.R.

Edwards

P.J.

Fader

L.D.

Jakalian

Hucke

. “Revealing Atropisomer Axial Chirality in Drug Discovery”. ChemMed-Chem. 2011. 6(3): 505–513.

Cross

Hawkes

G.E.

Kroemer

R.T.

Liedl

C.R.

Loerting

Nasser

Pritchard

R.G.

Steele

Watkinson

Whiting

. “ The Structure, Modeling and Dynamics of Hindered 5,6-Diarylacenaphthenes”. J. Chem. Soc. Perkin Trans. B. 2001. 4: 459–467.

Zhou

Y.S.

Tay

L.K.

Hughes

Donahue

. “Simulation of the Impact of Atropisomer Interconversion on Plasma Exposure of Atropisomers of an Endothelin Receptor Antagonist”. J. Clin. Pharmacol. 2004. 44(7): 680–688.

Liu

X.F.

Chang

H.-F.

Schmiesing

R.J.

Wesolowski

S.S.

Knappenberger

K.S.

Arriza

J.L.

Chapdelaine

M.J.

. “Developing Dual Functional Allosteric Modulators of GABAA Receptors”. Bioorg. Med. Chem. 2010. 18(23): 8374–8382.

Alhambra

Becker

Blake

Chang

Damewood

J.R.

Daniels

Dembofsky

B.T.

Gurley

D.A.

Hall

J.E.

Herzog

K.J.

Horchler

C.L.

Ohnmacht

C.J.

Schmiesing

R.J.

Dudley

Ribadeneira

M.D.

Knappenberger

K.S.

Maciag

Stein

M.M.

Chopra

Liu

X.F.

Christian

E.P.

Arriza

J.L.

Chapdelaine

M.J.

. “Development and SAR of Functionally Selective Allosteric Modulators of GABAA Receptors”. Bioorg. Med. Chem. 2011. 19(9): 2927–2938.

10.

Nafie

L.A.

Dukor

R.K.

. “Applications of Vibrational Optical Activity in the Pharmaceutical Industry”. In: Pivonka

D.E.

Chalmers

J.M.

Griffiths

P.R.

, editors. Application of Vibrational Spectroscopy in Pharmaceutical Research and Development. West Sussex, Chichester, UK: John Wiley and Sons, 2007. Pp. 129–154.

11.

Stephens

P.J.

. “Theory of Vibrational Circular Dichroism”. J. Phys. Chem. 1995. 89(5): 748–752.

12.

Rauk

. “Vibrational Circular Dichroism Intensities: Ab Initio Calculations. Understanding Chemical Reactivity”. In: Mezey

P.G.

, editor. New Developments in Molecular Chirality. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1991. Pp. 57–92.

13.

Nafie

L.A.

Freedman

T.B.

. “Vibronic Coupling Theory of Infrared Vibrational Transitions”. J. Chem. Phys. 1983. 78(12): 7108–7116.

14.

Crawford

T.D.

. “Ab Initio Calculation of Molecular Chiroptical Properties”. Theor. Chem. Acc. 2000. 115(4): 227–245.